Crucell « Terug naar discussie overzicht

CRUCELL KONDIGT PER.C6-LICENTIEOVEREENKOMST

4 Posts
[verwijderd]
0
Crucell Announces PER.C6® Licensing Agreement with Pfizer Animal Health




Leiden, The Netherlands, March 15, 2007- Dutch biotechnology company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) and Pfizer Animal Health today announced the signing of a research license agreement for PER.C6®. The license agreement allows Pfizer Animal Health to use Crucell's industry-leading PER.C6® cell technology in the production of a non-disclosed veterinary vaccine. Pfizer Animal Health has an option to convert the research license into a commercial agreement. Financial details were not disclosed.

4 Posts
Aantal posts per pagina:  20 50 100 | Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met uw e-mailadres en wachtwoord.

Direct naar Forum

Markt vandaag

 AEX
946,61  +0,03  +0,00%  14 feb
 Germany40^ 22.504,40 -0,48%
 BEL 20 4.396,58 -0,82%
 Europe50^ 5.480,25 -0,24%
 US30^ 44.524,90 0,00%
 Nasd100^ 22.109,50 0,00%
 US500^ 6.112,09 0,00%
 Japan225^ 39.114,70 0,00%
 Gold spot 2.882,65 0,00%
 EUR/USD 1,0493 +0,24%
 WTI 70,68 0,00%
#/^ Index indications calculated real time, zie disclaimer

Stijgers

BAM +10,11%
PROSUS +4,70%
HEIJMANS KON +4,21%
NX FILTRATION +3,58%
Aperam +3,30%

Dalers

Arcadis -2,88%
IMCD -1,93%
Philips Konin... -1,92%
UNILEVER PLC -1,82%
Wereldhave -1,77%

EU stocks, real time, by Cboe Europe Ltd.; Other, Euronext & US stocks by NYSE & Cboe BZX Exchange, 15 min. delayed
#/^ Index indications calculated real time, zie disclaimer, streaming powered by: Infront